Clinical Trials Directory

Trials / Terminated

TerminatedNCT01068119

Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)

Feasibility and Safety of Same-Day Discharge of Troponin Negative Patients After Coronary PTCA Via the Transfemoral Approach

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Piedmont Healthcare · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Same day discharge is safe and feasible in selected troponin negative patients undergoing coronary planned percutaneous coronary intervention (PCI) or ad hoc PCI via the transfemoral approach.

Detailed description

The feasibility and safety of same day discharge post PCI will be examined. Study data will be compared to national registries and national or regional databases of PCI in Troponin negative patients with overnight stay. As part of the registry we will also assess compliance with dual antiplatelet therapy at six months and at 1 year and will record any reasons for premature discontinuation as well as any associated adverse events.

Conditions

Interventions

TypeNameDescription
PROCEDURESame-day dischargePatients identified as clinically stable are discharged home the same day as the PCI procedure with telephone follow-up at 12 hr, 24 hr, 3, 30, 180 and 365 days post procedure.

Timeline

Start date
2010-02-01
Primary completion
2011-08-01
Completion
2012-03-01
First posted
2010-02-12
Last updated
2013-09-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01068119. Inclusion in this directory is not an endorsement.